login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CABALETTA BIO INC (CABA) Stock News
USA
- NASDAQ:CABA -
US12674W1099
-
Common Stock
2.38
USD
+0.02 (+0.85%)
Last: 9/29/2025, 8:00:01 PM
2.37
USD
-0.01 (-0.42%)
After Hours:
9/29/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CABA Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Cabaletta Bio
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
2 months ago - By: Zacks Investment Research
Cabaletta Bio (CABA) Upgraded to Buy: Here's Why
2 months ago - By: Benzinga
- Mentions:
NVAX
SRPT
QURE
MRNA
...
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
2 months ago - By: The Motley Fool
Cabaletta Bio (CABA) Q2 Loss Widens 30%
2 months ago - By: Cabaletta Bio
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Proposed Public Offering of Securities
2 months ago - By: Cabaletta Bio
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Benzinga
- Mentions:
SRPT
QURE
CAPR
NTLA
...
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Pricing of Public Offering of Securities
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Pricing of Public Offering of Securities
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Proposed Public Offering of Securities
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
4 months ago - By: Cabaletta Bio
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
4 months ago - By: Cabaletta Bio
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
4 months ago - By: Cabaletta Bio
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
5 months ago - By: Stocktwits
Cabaletta Bio Stock Surges To 2-Month High On Autoimmune Therapy Progress; Retail’s Pleased
5 months ago - By: Cabaletta Bio
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
5 months ago - By: Cabaletta Bio
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
6 months ago - By: Cabaletta Bio
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
6 months ago - By: Cabaletta Bio
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
6 months ago - By: Cellares
Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
7 months ago - By: Cabaletta Bio
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
7 months ago - By: Cabaletta Bio
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
7 months ago - By: Cabaletta Bio
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
7 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
7 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
8 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
8 months ago - By: Cabaletta Bio
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
8 months ago - By: Cabaletta Bio
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
Please enable JavaScript to continue using this application.